Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Scott Duncan currently holds 68,786 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Scott Duncan has been a net buyer of VIRI stock. They have purchased $288.6K and sold $0 worth of shares.
Gregory Scott Duncan's most recent insider trade was on Jan 26, 2026, when they sold 30,453 shares at $0.00 per share.
Gregory Scott Duncan serves as Executive at Virios Therapeutics, Inc. (VIRI). They have executed 11 insider transactions totaling $288.6K over their tenure at the company.
Gregory Scott Duncan holds the position of Executive at Virios Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Gregory Scott Duncan has shown a buying trading pattern, with $288.6K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gregory Scott Duncan was on Sep 16, 2025, when they sold $110.9K worth of CRMD shares. This transaction involved 13,333 shares at $8.32 per share.
Gregory Scott Duncan currently owns 68,786 shares of Virios Therapeutics, Inc. (VIRI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Scott Duncan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Scott Duncan has 11 Form 4 filings on record as an insider at Virios Therapeutics, Inc..
Set alerts for Gregory Scott Duncan and 40,000+ other insiders.